We are live on ! Find out more
ROIV icon

Roivant Sciences

293 hedge funds and large institutions have $5.77B invested in Roivant Sciences in 2024 Q2 according to their latest regulatory filings, with 64 funds opening new positions, 102 increasing their positions, 83 reducing their positions, and 26 closing their positions.

New
Increased
Maintained
Reduced
Closed

146% more first-time investments, than exits

New positions opened: 64 | Existing positions closed: 26

23% more repeat investments, than reductions

Existing positions increased: 102 | Existing positions reduced: 83

13% more funds holding

Funds holding: 259293 (+34)

7.91% more ownership

Funds ownership: 65.97%73.88% (+7.9%)

3% more capital invested

Capital invested by funds: $5.6B → $5.77B (+$165M)

0% more funds holding in top 10

Funds holding in top 10: 1919 (0)

12% less call options, than puts

Call options by funds: $14.4M | Put options by funds: $16.4M

Holders
293
Holders Change
+34
Holders Change %
+13.13%
% of All Funds
4.23%
Holding in Top 10
19
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.27%
New
64
Increased
102
Reduced
83
Closed
26
Calls
$14.4M
Puts
$16.4M
Net Calls
-$2.01M
Net Calls Change
+$472K
Name Holding Trade Value Shares
Change
Change in
Stake
Natixis Advisors
126
Natixis Advisors
Massachusetts
$1.5M +$167K +15,280 +12%
EAMA
127
EFG Asset Management (Americas)
Florida
$1.47M +$666K +60,758 +78%
State of Tennessee, Department of Treasury
128
State of Tennessee, Department of Treasury
Tennessee
$1.46M +$1.52M +138,414 New
Ohio Public Employees Retirement System (OPERS)
129
Ohio Public Employees Retirement System (OPERS)
Ohio
$1.41M -$60.7K -5,539 -4%
JFG
130
Jefferies Financial Group
New York
$1.4M +$1.45M +132,500 New
Allspring Global Investments
131
Allspring Global Investments
North Carolina
$1.38M +$660K +60,221 +86%
AWM
132
AE Wealth Management
Kansas
$1.35M +$1.4M +127,317 New
HS
133
HighVista Strategies
Massachusetts
$1.34M -$936K -85,377 -40%
CM
134
Caption Management
Oklahoma
$1.31M +$1.36M +124,330 New
UOC
135
UBS O'Connor
Illinois
$1.31M +$296K +27,000 +28%
SSA
136
Schonfeld Strategic Advisors
New York
$1.28M -$7.26M -662,449 -85%
Ensign Peak Advisors
137
Ensign Peak Advisors
Utah
$1.25M
Handelsbanken Fonder
138
Handelsbanken Fonder
Sweden
$1.21M -$108K -9,900 -8%
CP
139
CenterBook Partners
Connecticut
$1.13M +$1.17M +106,522 New
HSA
140
Hussman Strategic Advisors
Maryland
$1.11M
ASRS
141
Arizona State Retirement System
Arizona
$1.07M +$267K +24,333 +31%
IC
142
Ikarian Capital
Texas
$1.06M
Cetera Investment Advisers
143
Cetera Investment Advisers
Illinois
$1.06M +$310K +28,324 +39%
P
144
Paradiem
Louisiana
$1.02M +$1.06M +96,616 New
LSERS
145
Louisiana State Employees Retirement System
Louisiana
$1.01M -$14.2K -1,300 -1%
Mirae Asset Global ETFs Holdings
146
Mirae Asset Global ETFs Holdings
Hong Kong
$967K +$1M +91,444 New
BHCM
147
Brevan Howard Capital Management
Jersey
$959K +$994K +90,726 New
EWM
148
Edge Wealth Management
New York
$954K
ICM
149
Ionic Capital Management
New York
$951K +$438K +40,000 +80%
DLP
150
De Lisle Partners
United Kingdom
$951K

ROIV Hedge Fund Activity: Q2 2024 in Review

293 of the 6,924 institutional investors tracked by Wall St. Rank reported a position in Roivant Sciences (ROIV) for Q2 2024, worth a combined $5.77B — up 2.9% from $5.6B a quarter earlier.

Buyers outnumbered sellers: 64 funds opened new ROIV positions and 26 closed out — a net gain of 38 holders — while 102 added to existing stakes and 83 trimmed.

The largest buyer was Fidelity Investments, adding an estimated $123M. The largest seller was Morgan Stanley, cutting an estimated $69.1M.

  • 293 institutional investors held Roivant Sciences (ROIV) as of Q2 2024, up from 259 in Q1 2024.
  • Funds reported $5.77B of Roivant Sciences stock for Q2 2024, up 2.9% quarter-over-quarter.
  • 64 funds opened new Roivant Sciences positions in Q2 2024 and 26 closed out, a net change of +38 holders.
  • The largest Roivant Sciences buyer in Q2 2024 was Fidelity Investments, an estimated $123M added.
  • The largest Roivant Sciences seller in Q2 2024 was Morgan Stanley, an estimated $69.1M sold.

Based on aggregated 13F filings for Q2 2024.